Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Adagio Therapeutics Inc (NQ: ADGI )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 12, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Adagio Therapeutics Inc

< Previous 1 2 3 4 5 6 Next >
Mid-Morning Market Update: Markets Mostly Lower; Producer Prices Rise 0.8% In November
Following the market opening Tuesday, the Dow traded up 0.06% to 35,673.60 while the NASDAQ fell 1.08% to 15,247.22. The S&P also fell, dropping 0.57% to 4,642.29. The U.S.... 
Via Benzinga
54 Biggest Movers From Yesterday
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 66.7% to close at $4.60 on Tuesday. Siyata Mobile received $1.3 million purchase order for SD7 ruggedized devices and... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 200.4% to close at $15.05 on Monday after the company announced the commencement of a formal process to explore... 
Via Benzinga
36 Stocks Moving In Monday's Mid-Day Session
Gainers Del Taco Restaurants, Inc. (NASDAQ: TACO) shares jumped 64.6% to $12.40. Jack In The Box Inc (NASDAQ: JACK) agreed to acquire Del Taco Restaurants for $12.51 per share... 
Via Benzinga
Will Adagio's COVID Antibody Therapy Be Too Late to the Party?
It's quite possible. 
Via The Motley Fool
Exposures COVID-19
Stock Market Rally Hammered On Hawkish Fed, Omicron Fears; Salesforce, Snowflake, DocuSign, Xpeng In Focus: Weekly Review
Stocks suffered sharp losses, amid omicron fears and a more-hawkish Fed. 
Via Investor's Business Daily
Topics Bonds Economy Stocks
Exposures Debt Markets Fossil Fuels Interest Rates
Spatial Computing Stocks: 14 Things to Know About Matterport as MTTR Gives Back Some Gains Today
Matterport (MTTR) stock is taking a beating on Tuesday as the spatial computing company pulls back from a recent rally of its shares. 
Via InvestorPlace
META ETF: 10 Things to Know About the Roundhill Ball Metaverse ETF
Roundhill Ball Metaverse ETF (META) is catching the eyes of investors today as extra interest is placed on Metaverse ETFs. 
Via InvestorPlace
Adagio Continues Its Run As Biotech Stocks Moderna, BioNTech Dive On Omicron Threat
Biotech stocks diverged Tuesday with Adagio continuing a run on the potential for its antibody to target Covid's omicron variant. 
Via Investor's Business Daily
35 Stocks Moving In Tuesday's Mid-Day Session
Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares jumped 105.9% to $4.53. The FDA approved expanded labeling for Cumberland Pharmaceuticals’ Caldolor, an... 
Via Benzinga
Exposures Product Safety
ADGI Stock: The Social Media Chatter That Has Adagio Therapeutics Soaring Today
Adagio Therapeutics (ADGI) stock is rising higher on Tuesday as investors on social media can't stop talking about the company. 
Via InvestorPlace
Exposures COVID-19
Mid-Morning Market Update: Markets Mostly Lower; JinkoSolar Issues Weak Sales Forecast
Following the market opening Tuesday, the Dow traded down 0.60% to 34,923.74 while the NASDAQ climbed 0.16% to 15,807.66. The S&P also fell, dropping 0.32% to 4,640.44... 
Via Benzinga
Topics Stocks
Exposures US Equities
ADGI Stock Soars as Analysts Lock On to Its Omicron-Fighting Potential
Shares of ADGI stock are soaring higher by 80% after the company stated that its ADG-20 antibody is effective against the omicron variant. 
Via InvestorPlace
Exposures COVID-19
Mid-Afternoon Market Update: Dow Jumps 300 Points; Krystal Biotech Shares Spike Higher
Toward the end of trading Monday, the Dow traded up 0.87% to 35,204.42 while the NASDAQ climbed 1.96% to 15,795.08. The S&P also rose, gaining 1.55% to 4,665.67. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
50 Biggest Movers From Yesterday
Gainers Krystal Biotech, Inc. (NASDAQ: KRYS) shares surged 121.7% to close at $88.24 on Monday after the company announced positive topline results from the GEM-3 Phase 3 trial... 
Via Benzinga
Adagio shares soar on antibody potential against new COVID variant omicron
Stifel analyst Stephen Willey believes vaccines alone are unlikely to sufficiently address the COVID-19 pandemic. 
Via Talk Markets
Exposures COVID-19
3 Pharma Stocks Morgan Stanley Says Will Be Omicron Variant Beneficiaries
The news of a new variant of the coronavirus Friday sent financial markets into a tailspin. The adversity could present an opportunity for a h... 
Via Benzinga
Exposures COVID-19
Mid-Day Market Update: Crude Oil Rises 4%; Fennec Pharmaceuticals Shares Slide
Midway through trading Monday, the Dow traded up 0.30% to 35,005.10 while the NASDAQ climbed 1.39% to 15,707.48. The S&P also rose, gaining 0.97% to 4,639.11. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
33 Stocks Moving In Monday's Mid-Day Session
Gainers Krystal Biotech, Inc. (NASDAQ: KRYS) shares jumped 116.4% to $86.13 after the company announced positive topline results from the GEM-3 Phase 3 trial of investigational... 
Via Benzinga
Vaccine Stocks Ask The Unthinkable: What Happens If Today's Covid Shots Fail?
Smaller companies are working on next-generation approaches to Covid treatment. 
Via Investor's Business Daily
Mid-Morning Market Update: Markets Open Higher; Li Auto Sales Top Views
Following the market opening Monday, the Dow traded up 0.22% to 34,977.01 while the NASDAQ climbed 1.53% to 15,727.94. The S&P also rose, gaining 0.92% to 4,637.03. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2021
Upgrades According to Odeon Capital, the prior rating for Wells Fargo & Co (NYSE: 
Via Benzinga
Adagio Says Its COVID-19 Antibody Likely To Retain Activity Against Omicron Variant
Adagio Therapeutics Inc (NASDAQ: ADGI) says that its COVID-19 monoclonal antibody, ADG20, is likely to retain activity against Omicron, as observed in in vitro models... 
Via Benzinga
Exposures COVID-19
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
I hope you got your rest out over the holiday weekend because we're starting off Monday with the biggest pre-market stock movers! 
Via InvestorPlace
Exposures COVID-19
56 Biggest Movers From Friday
Gainers iSpecimen Inc. (NASDAQ: ISPC) climbed 71.7% to settle at $17.51 on Friday. The company recently announced it has been contracted to support new advanced research on... 
Via Benzinga
Mid-Day Market Update: Dow Tumbles Over 900 Points; Crude Oil Down 12%
Midway through trading Friday, the Dow traded down 2.60% to 34,873.25 while the NASDAQ fell 1.84% to 15,553.65 after a new COVID-19 variant was detected in South Africa.... 
Via Benzinga
Topics Stocks
Exposures COVID-19 Fossil Fuels US Equities
48 Stocks Moving In Friday's Mid-Day Session
Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares jumped 68% to $9.04. Shares of mask and protective apparel companies, including Allied Healthcare Products, traded... 
Via Benzinga
Mid-Morning Market Update: Markets Open Lower; Europe's Regulator Backs Pfizer's COVID-19 Vaccine For Kids Aged 5-11 Years
Following the market opening Friday, the Dow traded down 2.57% to 34,885.52 while the NASDAQ fell 1.55% to 15,599.06 after a new COVID-19 variant was detected in South Africa. The... 
Via Benzinga
Topics Stocks
Exposures COVID-19 US Equities
64 Stocks Moving In Friday's Mid-Day Session
Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the... 
Via Benzinga
92 Biggest Movers From Friday
Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares jumped 99.8% to close at $9.99 on Friday. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.